The Neuroscience Report—Volume 39 (April 11, 2016): Rapid-acting Antidepressants
The latest in neuroscience—sorted and summarized for you
Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information.
This week’s topic: Rapid-acting Antidepressants
Journal Articles
Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants
Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy
Neurobiology of Stress, Depression, and Rapid Acting Antidepressants: Remodeling Synaptic Connections
Circadian Dysregulation of Clock Genes: Clues to Rapid Treatments in Major Depressive Disorder
Ketamine and Other N-methyl-D-aspartate Receptor Antagonists in the Treatment of Depression: A Perspective Review
News Articles
Scientists Seek Fast-acting Antidepressant, from Ketamine to Laughing Gas
Five New NMDA Receptor (Glutamate) Modulators For Depression
Rapastinel: A Novel Approach to Depression?
The Search for a “Safer” Ketamine
Novel Route for Ketamine in the Treatment of MDD
Wildcards
20 New Antidepressants In The Pipeline (2015): Drugs In Clinical Trials
Depression: My Story About the Power of Medication
Why We’ve Probably Overestimated the Benefits of Psychotherapy for Depression
The Mental Illness Drunk Tank
Ketamine: Life Saver...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: ICN Online Editor Tags: Drug Development Mood Disorders Psychiatry Psychopharmacology The Neuroscience Report glutamate Ketamine N-methyl-D-aspartate NMDA rapid acting antidepressant Source Type: research
More News: Brain | Clinical Trials | Depression | Genetics | Men | Neurology | Neuroscience | Psychiatry | Psychotherapy